Leading the Science of Protection - Cidara Therapeutics
Cidara is developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious diseases. Antifungal: REZAFUNGIN A next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections Cloudbreak® Drug-Fc Conjugates Highly potent, long-acting, drug-Fc conjugates (DFCs) designed to inhibit...
Stats
Alexa Rank:
Popular in Country:
Country Alexa Rank:
language: en-US
Response Time: 1.141222
SSL: Disable
Status: up
Code To Txt Ratio
Word Count 410
Links
ratio 3.3295047570814
Found 77 Top Alternative to Cidara.com
15.197.142.173
United States
InValid
SSL
Poseida.com
Home - Poseida Therapeutics
Poseida Therapeutics is a clinical-stage biopharmaceutical company leveraging its proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical needs.
Bioxceltherapeutics.com
BioXcel Therapeutics Inc – BioXcel Therapeutics Inc
Innovative Medicine Backed by the Power of AI BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches. Innovative Medicine Backed by the Power of AI BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and...
Onconova.com
Onconova Therapeutics, Inc. - A Biopharmaceutical Company
Onconova Therapeutics, Inc. is focused on discovering and developing novel small molecule drug candidates to treat cancer.
Sperotherapeutics.com
Developing MDR Bacterial Infection Treatments | Spero Therapeutics
Leading Product Candidates Spero Therapeutics is developing a portfolio of novel product candidates with the potential for meaningful patient impact and significant commercial applications. As a leader in the infectious disease field, we are highly committed to advancing new therapies for patients with serious infections. Our candidates are designed to...
Fatetherapeutics.com
Home - Fate Therapeutics
Privacy Overview This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you...
Halozyme.com
Home | Halozyme
Halozyme has completed its acquisition of Antares Pharma, Inc., creating a leading drug delivery business. View details here. Inspiring New Inspiring New As of May 24, 2022, Halozyme completed its acquisition of Antares Pharma Inc., creating a leading drug delivery business with broadly licensable opportunities across the ENHANZE® and Antares’...
Akebia.com
Home - Akebia Therapeutics
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Mirati.com
Mirati Therapeutics, Inc. | Relentless Focus on Innovation | Targeted Oncology
At Mirati, we are relentlessly focused on developing best-in-class targeted therapies to meaningfully impact the lives of patients with cancer.
Sorrentotherapeutics.com
Home - Sorrento Therapeutics
Sorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19
Amicusrx.com
Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases
Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.
Celldex.com
Celldex Therapeutics
Celldex is developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate.
Amphire.com
Amphire has moved
Comprehensive On Demand Supply chain Management Solutions including Spend Analysis, Sourcing, Contract Management, Supplier Negotiation, E-Procurement, and Supplier Performance
Herontx.com
Acute Care and Oncology Care Solutions | Heron Therapeutics
At Heron, we aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies to deliver medicines that matter.
Aclaristx.com
Home | Aclaris Therapeutics Inc.
Aclaris is a biopharmaceutical company that strives to translate scientific discoveries into everyday victories in dermatology, and beyond. Learn about our pipeline.
Rubiustx.com
Home - Rubius Therapeutics
Rubius Therapeutics | Red Cell Therapeutics™️ | Home Rubius Therapeutics is realizing the power of red by creating red blood cells and transforming them into cellular medicines. Learn More.
G1therapeutics.com
G1 Therapeutics, Inc. | Optimizing Chemotherapy, Advancing Survival
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer.
Allogene.com
Home - Allogene
THE NEXT REVOLUTION IN CELL THERAPY Allogene is developing allogeneic chimeric antigen receptor T cell (AlloCAR T™) products to find the next immunologic breakthrough in cancer. That’s how we’re leading today, creating tomorrow. LEARN ABOUT AlloCAR T™ THE NEXT REVOLUTION IN CELL THERAPY Allogene is developing allogeneic chimeric antigen receptor T...
Serestherapeutics.com
Establishing a Better Microbiome for Better Health - Seres Therapeutics
Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. Discover our progress.
Checkpointtx.com
Checkpoint
June 16, 2022 Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Locally Advanced Cutaneous Squamous Cell Carcinoma Read Article June 6, 2022 Checkpoint Therapeutics Announces Presentation of Pivotal Trial Results of Cosibelimab at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Read Article May...
Frequencytx.com
FX 322 | Regenerative Medicine | Hearing Restoration| Frequency Therapeutics
Frequency Therapeutics is actively working to transform the treatment of hearing loss. Learn more about our approach to degenerative diseases.
Tgtherapeutics.com
TG Therapeutics
ABOUT US Our Story Message From Our CEO Leadership Team Board Members Guiding Principles Join Us OUR SCIENCE Our Approach Our Focus MZL/FL CLL MS Collaborate With Us Meet with TG Medical OUR PRODUCTS OUR PIPELINE Overview Umbralisib Ublituximab TG-1501 TG-1701 TG 1801 OUR PUBLICATIONS OUR TRIALS Trial Information Expanded...
Formatherapeutics.com
Clinical-Stage Biopharmaceutical Company - Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Capricor.com
Capricor Therapeutics
Capricor is Developing Transformative Cell and Exosome-based Therapeutics for the Treatment and prevention of Diseases
Voyagertherapeutics.com
Voyager Therapeutics
Unlocking breakthroughs in AAV gene therapy and developing best-in-class treatments for CNS and other diseases.
Acorda.com
Acorda Therapeutics Biotechnology Company | MS and Spinal Cord Injury Treatments
Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis
Safecarecampaign.org
Safe Care Campaign | Welcome
Safe Care Campaign is an organization dedicated on early prevention and detection of all types of infections
Technologies Used by cidara.com
Dns Records of cidara.com
A Record: 104.198.5.36AAAA Record:
CNAME Record:
NS Record: ns-369.awsdns-46.com ns-1597.awsdns-07.co.uk ns-1368.awsdns-43.org ns-923.awsdns-51.net
SOA Record: awsdns-hostmaster.amazon.com
MX Record: mx1-us1.ppe-hosted.com mx2-us1.ppe-hosted.com
SRV Record:
TXT Record: 69oOdqwSteviVsPb58MGKFoP1Z+VxQp31ZeOrsh7/P4N0QHIgH8O4u4bMqKEOTeE+7DkwGJ2ZygMkVmBZpRpNA== v=spf1 ip4:4.79.33.132/32 ip4:209.170.209.135/32 a:dispatch-us.ppe-hosted.com include:spf.tipalti.com include:spf.protection.outlook.com ~all ppe-a5a2445b3b5c7234423e citrix-verification-code=90df0cd8-bd64-45ac-b6ef-e437166b3355 ZOOM_verify_vqFUTyJWQDWbf5YCuVpvxQ MS=ms85676367
DNSKEY Record:
CAA Record:
Whois Detail of cidara.com
Domain Name: cidara.comRegistry Domain ID: 1864165545_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2021-04-26T17:12:16+0000
Creation Date: 2014-06-24T22:17:55+0000
Registrar Registration Expiration Date: 2023-06-24T22:17:55+0000
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.2083895770
Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)
Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)
Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)
Registry Registrant ID:
Registrant Name: Domain Administrator
Registrant Organization: DNStination Inc.
Registrant Street: 3450 Sacramento Street, Suite 405
Registrant City: San Francisco
Registrant State/Province: CA
Registrant Postal Code: 94118
Registrant Country: US
Registrant Phone: +1.4155319335
Registrant Phone Ext:
Registrant Fax: +1.4155319336
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: Domain Administrator
Admin Organization: DNStination Inc.
Admin Street: 3450 Sacramento Street, Suite 405
Admin City: San Francisco
Admin State/Province: CA
Admin Postal Code: 94118
Admin Country: US
Admin Phone: +1.4155319335
Admin Phone Ext:
Admin Fax: +1.4155319336
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID:
Tech Name: Domain Administrator
Tech Organization: DNStination Inc.
Tech Street: 3450 Sacramento Street, Suite 405
Tech City: San Francisco
Tech State/Province: CA
Tech Postal Code: 94118
Tech Country: US
Tech Phone: +1.4155319335
Tech Phone Ext:
Tech Fax: +1.4155319336
Tech Fax Ext:
Tech Email: [email protected]
Name Server: ns-1368.awsdns-43.org
Name Server: ns-923.awsdns-51.net
Name Server: ns-1597.awsdns-07.co.uk
Name Server: ns-369.awsdns-46.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2022-07-27T03:10:16+0000 <<<
For more information on WHOIS status codes, please visit:
https://www.icann.org/resources/pages/epp-status-codes
If you wish to contact this domain’s Registrant, Administrative, or Technical
contact, and such email address is not visible above, you may do so via our web
form, pursuant to ICANN’s Temporary Specification. To verify that you are not a
robot, please enter your email address to receive a link to a page that
facilitates email communication with the relevant contact(s).
Web-based WHOIS:
https://domains.markmonitor.com/whois
If you have a legitimate interest in viewing the non-public WHOIS details, send
your request and the reasons for your request to [email protected]
and specify the domain name in the subject line. We will review that request and
may ask for supporting documentation and explanation.
The data in MarkMonitor’s WHOIS database is provided for information purposes,
and to assist persons in obtaining information about or related to a domain
name’s registration record. While MarkMonitor believes the data to be accurate,
the data is provided "as is" with no guarantee or warranties regarding its
accuracy.
By submitting a WHOIS query, you agree that you will use this data only for
lawful purposes and that, under no circumstances will you use this data to:
(1) allow, enable, or otherwise support the transmission by email, telephone,
or facsimile of mass, unsolicited, commercial advertising, or spam; or
(2) enable high volume, automated, or electronic processes that send queries,
data, or email to MarkMonitor (or its systems) or the domain name contacts (or
its systems).
MarkMonitor reserves the right to modify these terms at any time.
By submitting this query, you agree to abide by this policy.
MarkMonitor Domain Management(TM)
Protecting companies and consumers in a digital world.
Visit MarkMonitor at https://www.markmonitor.com
Contact us at +1.8007459229
In Europe, at +44.02032062220